Skip to main navigation Skip to search Skip to main content

Randomized, Multi-Center, Double-Blind, Placebo Controlled Study: Assess Prevention of Bone Loss by Treatment w/GL701 (Prestara) in Women w/Systematic Lupus Erythematosus Receiving Treatment w/Glucocorticoids

Project: Research

Project Details

StatusFinished
Effective start/end date02/7/03 → 02/6/05

Funding

  • Genelabs Technologies Incorporated: $50,825.00